These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 12794428

  • 1. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED, de Groot R, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA.
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [Abstract] [Full Text] [Related]

  • 2. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE, Veldmann A, Beeg T, Schneider W, Jäger G, Kreuz W.
    Semin Thromb Hemost; 1999 Jun; 25(6):537-41. PubMed ID: 10632475
    [Abstract] [Full Text] [Related]

  • 3. Use of protein C concentrate in pediatric patients with sepsis.
    Silvani P, Camporesi A, Licari E, Wolfler A.
    Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
    [Abstract] [Full Text] [Related]

  • 4. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
    Schellongowski P, Bauer E, Holzinger U, Staudinger T, Frass M, Laczika K, Locker GJ, Quehenberger P, Rabitsch W, Schenk P, Knöbl P.
    Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
    [Abstract] [Full Text] [Related]

  • 5. Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans.
    Vaccarella G, Pelella R.
    Minerva Anestesiol; 2003 Sep; 69(9):691-3, 693-5. PubMed ID: 14564239
    [Abstract] [Full Text] [Related]

  • 6. [Meningococcal purpura fulminans: treatment with recombinant protein C activator in 3 cases].
    Salinas U, Unzueta J, Vidarte MA, Rodrigo MP, Gómez JJ, Aguilera L.
    Rev Esp Anestesiol Reanim; 2007 Oct; 54(8):503-6. PubMed ID: 17993100
    [Abstract] [Full Text] [Related]

  • 7. Treatment of acute infectious purpura fulminans with activated protein C.
    Lokeshwar MR, Singhal T, Udani SV, Kapadia FN.
    Indian Pediatr; 2006 Jun; 43(6):535-8. PubMed ID: 16820663
    [Abstract] [Full Text] [Related]

  • 8. The current management of septic shock.
    Russel JA.
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
    Baratto F, Michielan F, Gagliardi G, Di Gregorio G, Pasqualetto A, Meroni M, Giron GP.
    Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.
    White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP.
    Blood; 2000 Dec 01; 96(12):3719-24. PubMed ID: 11090052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levels of protein C activity and clinical factors in early phase of pediatric septic shock may be associated with the risk of death.
    Samransamruajkit R, Hiranrat T, Prapphal N, Sritippayawan S, Deerojanawong J, Poovorawan Y.
    Shock; 2007 Nov 01; 28(5):518-23. PubMed ID: 17589380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.